What sits inside pharma medical information outsourcing?
Answering unsolicited questions about your products from healthcare professionals, pharmacists, patients and caregivers. Pharmacist-led agents take inquiries by phone, email, chat and web, search approved standard response documents, give balanced, non-promotional answers within the label and your policies, escalate complex questions to your medical team, and capture any adverse event or product complaint for your safety and quality teams. Processing those safety reports is covered on pharmacovigilance outsourcing.
Medical information is where science meets the phone. Answers must be accurate, approved and balanced, and every call may also be a safety report.
Inside the medical information team: four jobs.
Most companies start with phone and email inquiries for marketed products, then add launches, chat and response document support.
Answer unsolicited questions from doctors, pharmacists, nurses, patients and caregivers using approved standard responses.
Route questions without an approved answer to your medical information scientists with the full context, and close the loop with the requester.
Screen every contact for adverse events and product complaints, collect the key facts and hand them to safety and quality inside your timelines.
See pharmacovigilance →Keep the response library current, track content gaps, send written responses and fulfil literature requests.
Where a medical information inquiry goes
Most inquiries are answered from approved responses. The ladder shows when a question moves up.
The buyers behind outsourced pharma medical information.
Companies with marketed or soon-to-launch products that must answer questions from healthcare professionals and the public accurately and on time.
How the desk is run
Tier 1 pharmacist agents answer from approved content. Questions without an approved response go to your medical information scientists, and every contact is screened for adverse events and product complaints.
Two places outsourced medical information loses time.
Both are fixable before go-live.
Who outsources medical information, and where it strains.
Several brands, small in-house teams and calls that peak with launches.
First commercial product and no medical information desk yet.
Complex products and highly specific HCP questions.
Large portfolios and high patient call volumes.
2026 rates by role — fully loaded, per hour
Ask each vendor to price against your products, monthly inquiries, channels and languages. Rates confirmed per engagement.
Scope my medical information team →Generalist BPO or a vetted medical information team: what changes.
Where a general healthcare contact center and a pharmacist-led medical information team differ.
Pharma medical information outsourcing in the Philippines: science on the phone
Pharma medical information outsourcing to the Philippines gives drug and biotech companies a contact center for one of their most sensitive conversations: a healthcare professional or patient asking a scientific question about a product. Answers must be accurate, balanced and based on approved content, and the contact may also contain safety information that has to be reported.
The Philippines has a large pool of licensed pharmacists who speak clear English and are trained in pharmacology, which is why many global companies already run medical information here. Hubs in Manila, Cebu and Clark cover US and EU business hours, and after-hours lines for urgent questions. For the wider picture, see our guides to digital-first pharma support and FDA compliance in pharma outsourcing.
Approved responses and unsolicited questions
Agents answer from a library of standard response documents approved by your medical, legal and regulatory reviewers. They match the requester and question to the right response, explain it in plain terms for patients or in clinical terms for healthcare professionals, and send written responses when requested.
Questions about unapproved uses must be unsolicited and answered in a scientific, non-promotional way under your policies and FDA guidance on communications about unapproved uses. Agents follow a defined route for these, usually escalating to your medical information scientists, and record each one.
Adverse events and product complaints
Many medical information calls contain a possible adverse event or product complaint, even when the caller only asked a question. Agents screen every contact, collect the minimum information needed and hand it to your safety and quality teams within your timelines. Day zero starts when the agent hears it.
Product complaints, such as a damaged pack or a device that will not work, are captured with batch numbers and sample return details. Good vendors audit a sample of calls each month specifically for missed safety information and report reconciliation between medical information, safety and quality systems.
Healthcare professional inquiries and response documents
Healthcare professionals ask detailed questions: dosing in special populations, drug interactions, compatibility, storage after opening, clinical trial data and comparisons. Medical information specialists answer from standard response documents approved by medical affairs, search the literature where needed and draft custom responses for medical review when no standard response exists.
Response quality depends on a well-maintained library of standard responses. Teams track which questions lack responses and propose new documents to medical affairs. See pharmacovigilance for the safety side of inquiries and life sciences outsourcing for the shared framework.
Multichannel medical information
Medical information is no longer only a phone line. Inquiries arrive by email, web forms, live chat, field representatives and medical science liaisons, and increasingly through chatbots that answer common questions. Every channel must capture inquiries, adverse events and complaints, and route them consistently. Specialists work across channels with the same approved content.
Chatbot answers need human review and clear escalation to specialists. See AI verification for reviewing AI outputs and live chat support for chat operations.
Compliance: promotional rules and documentation
Medical information must stay non-promotional. Responses to unsolicited off-label questions follow regulator guidance on scientific exchange, and every inquiry and response is documented in the medical information database with the requester, question, response and date. Requests generated by sales teams require scrutiny to confirm they are truly unsolicited.
Audits and inspections review inquiry records, response documents and safety capture. See our compliance guide and pharma outsourcing for related regulated functions.
Global coverage, languages and time zones
Global and regional medical information services need coverage in many languages and time zones, with local product labeling and approved responses for each market. Teams in the Philippines provide English coverage across markets and multilingual specialists for other languages, working from market-specific content approved by local medical affairs.
Follow-the-sun coverage and overflow support during launches keep response times steady. See multilingual call center for language desk design and bilingual support for English and Spanish programs.
Medical information as a source of insight
Medical information inquiries reveal what healthcare professionals do not understand, which questions follow new data and where competitor products create confusion. Specialists tag inquiries by topic, and monthly insight reports go to medical affairs, brand and safety teams. These insights shape education, publications and standard response updates.
See data analytics for reporting programs and research outsourcing for literature support.
Choosing a medical information partner
When you compare vendors, ask about pharmacist and nurse qualifications, medical information database experience, adverse event capture training, language coverage, launch staffing and how they keep content approval with medical affairs. Ask for sample procedures and quality metrics.
Vetted mid-sized Philippine providers usually start medical information programs with 4 to 25 specialists and report response times, first-contact resolution, safety capture accuracy, quality scores and inquiry insight reports. See the healthcare and life sciences hub.
Launches, insight and the metrics that matter
Launches bring call spikes and new questions. The team ramps with your launch plan, logs every question without an approved answer and reports themes, so your medical team can write new responses quickly. Over time, inquiry data shows where prescribers and patients are confused, which helps medical affairs and training.
Vetted mid-sized Philippine providers usually start medical information programs with 5 to 15 pharmacist-led staff and report response time, first-contact resolution, escalation rates, safety capture quality and inquiry themes by product.
When medical information should stay in-house.
How pharma medical information connects to the rest of healthcare.
Medical information has its own page because it answers product questions. Processing safety cases is a separate, regulated function.
HCP and patient product inquiries, escalation and AE capture.
Adverse event case processing to regulatory timelines.
Pharmacovigilance →Also serving: medical information sits in our Healthcare & Life Sciences hub. The sector page is pharma outsourcing, patient programs are on patient support, and safety case work on pharmacovigilance.
Related specialist pages: bioprocessing support.
What medical affairs leaders ask before they outsource medical information.
Straight answers to the questions that decide a medical information engagement, from the principals who run them.
